VATE
INNOVATE Corp.4.4900
+0.1700+3.94%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
61.31MP/E (TTM)
-Basic EPS (TTM)
-5.66Dividend Yield
0%Recent Filings
10-K
8-K
8-K
MediBeacon's tGFR article honored
INNOVATE disclosed that MediBeacon, its 44.7%-owned medtech affiliate, earned a top JASN Editors' Choice nod for its transdermal GFR article, spotlighted on the journal's August 2025 cover. Centers of Excellence rollout kicked off in January 2026, targeting heart failure, transplants, and oncology dosing. Recognition bolsters clinical credibility. Forward-looking risks include IP protection and product misuse.
8-K
DBM Global dividend announced
8-K
FDA approves MediBeacon TGFR Sensor
INNOVATE's 44.7%-owned MediBeacon secured FDA approval for its next-gen TGFR Reusable Sensor on December 16, 2025, enabling point-of-care kidney function assessment via non-radioactive Lumitrace tracer. The reusable design cuts costs versus prior single-use version. Centers of Excellence commercialization kicks off early 2026. IP risks loom large.
IPO
Website
Employees
Sector
Industry
GVA
Granite Construction Incorporat
116.65+0.94
IESC
IES Holdings, Inc.
447.35-6.08
INHD
Inno Holdings Inc.
0.11-0.02
LGN
Legence Corp.
41.92+1.08
MTZ
MasTec, Inc.
218.19-2.18
PRIM
Primoris Services Corporation
128.49-2.06
PWR
Quanta Services, Inc.
438.49+2.62
SHIM
Shimmick Corporation
2.92+0.33
STN
Stantec Inc
94.59+1.02
VMI
Valmont Industries, Inc.
410.66-1.31